Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
NYBD Holding, Inc.
SIC 5140 · Wholesale-Groceries & Related Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
NYBD Holding, Inc.
SIC 5140 · Wholesale-Groceries & Related Products
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
NYBD Holding, Inc.
SIC 5140 · Wholesale-Groceries & Related Products
Notes
Support
about
terms
$
CUEN
NYBD Holding, Inc.
CIK:
0001424657
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Unaudited Condensed Consolidated Interim Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses
Selling, General and administrative expenses
$ (803)
$ (320)
$ (1,136)
$ (603)
Total Operating expenses
(803)
(320)
(1,136)
(603)
Operating loss
(803)
(320)
(1,136)
(603)
Other income (expenses)
Interest (expenses) income, net
(3)
(6)
(31)
(20)
Income (loss) upon extinguishment of debt and default costs to pay principal and interest, net
704
602
Gain (loss) from Change in fair value of derivative warrants liability, net
(18)
(85)
Total other income (expenses)
(21)
698
(116)
582
Company’s share of equity losses
(64)
(133)
Net income (loss)
$ (888)
$ 378
$ (1,385)
$ (21)
Income (loss) per share basic (in Dollars per share)
$ (0.11)
$ 0.14
$ (0.21)
$ (0.01)
Income (loss) per share diluted (in Dollars per share)
$ (0.11)
$ 0.14
$ (0.21)
$ (0.01)
Basic weighted average number of shares of common stock outstanding (in Shares)
7,942,407
2,719,668
6,745,106
2,719,668
Diluted weighted average number of shares of common stock outstanding (in Shares)
7,942,407
2,719,668
6,745,106
2,719,668
v3.26.1
Unaudited Condensed Consolidated Interim Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
$ (1,385)
$ (21)
Adjustments required to reconcile net loss to net cash used in operating activities:
Stock based compensation and shares issued for services
47
37
Amortization of discounts and accrued interest on loans
31
20
Gain from change in fair value of derivative warrants liability
85
Company’s share of equity losses
133
Income upon extinguishment of debt and default costs to pay principal and interest, net
(602)
Changes in Operating Assets and Liabilities:
Decrease in other current assets
(8)
Changes in related parties, net
636
545
(Decrease) increase in accounts payable
(175)
(930)
Increase (decrease) in other accounts liabilities
352
(7)
Net cash used in operating activities
(276)
(966)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of investments in unconsolidated entities
825
Net cash provided by (used in) investing activities
825
CASH FLOWS FROM FINANCE ACTIVITIES:
Issued shares
300
Short term loans received
35
300
Repayment of loan from a related party
(115)
(173)
Net cash provided by finance activities
220
127
DECREASE IN CASH AND CASH EQUIVALENTS
(56)
(14)
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR
57
15
CASH AND CASH EQUIVALENTS AT END OF PERIOD
1
1
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTMENT AND FINANCING ACTIVITIES:
Issuance of Shares of common stock upon conversion of notes
373
Issuance of Shares of common stock in settlement of other liabilities
300
Cash paid during the period for interest
Cash paid during the period for taxes
v3.26.1
Unaudited Condensed Consolidated Interim Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current Assets
Cash and cash equivalents
$ 1
$ 57
Other receivables
Total Current Assets
272
841
Investment in unconsolidated entity
121
Total assets
272
962
Current Liabilities
Trade payable
1,435
1,545
Other accounts liabilities
1,388
1,246
Liabilities to an unconsolidated entity
60
175
Warrants liability, net
212
127
Notes and Loan payable
1,476
1,817
Total Current Liabilities
4,571
4,910
Long Term Liabilities
Investment in unconsolidated entity
12
Total Liabilities
4,583
4,910
Stockholders’ Deficit
Common stock, 0.001 par value each: 27,692,308 shares authorized as of June 30, 2026 and December 31, 2025, respectively; issued and outstanding 7,942,407 shares as of June 30, 2026 and 4,377,388 as of December 31, 2025.
8
4
Additional paid-in capital
56,925
55,836
Treasury Stock
(33)
(33)
Receipts on account of shares
71
Accumulated deficit
(61,211)
(59,826)
Total Stockholders’ Deficit
(4,311)
(3,948)
Total Liabilities and Stockholders’ Deficit
272
962
Related Party
Current Assets
Accounts Receivables – related parties
271
271
Other receivables – related parties
$ 513